Samuel Rabkin
Affiliations: | Harvard Medical School, Boston, MA, United States |
Area:
HSV Vectors for Cancer TherapyGoogle:
"Samuel Rabkin"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Epstein AL, Rabkin SD. (2024) Safety of non-replicative and oncolytic replication-selective HSV vectors. Trends in Molecular Medicine |
| Wang H, Borlongan M, Kaufman HL, et al. (2024) Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy? Journal For Immunotherapy of Cancer. 12 |
| Shimizu K, Kahramanian A, Jabbar MADA, et al. (2023) Photodynamic augmentation of oncolytic virus therapy for central nervous system malignancies. Cancer Letters. 572: 216363 |
| Kardani K, Sanchez Gil J, Rabkin SD. (2023) Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells. Frontiers in Cellular and Infection Microbiology. 13: 1206111 |
| Kawamura Y, Hua L, Gurtner A, et al. (2022) Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 155: 113843 |
| Jahan N, Ghouse SM, Martuza RL, et al. (2021) In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV. Viruses. 13 |
| Nguyen HM, Sah N, Humphrey MRM, et al. (2021) Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus. Journal of Visualized Experiments : Jove |
| Li M, Li G, Kiyokawa J, et al. (2020) Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma. Acta Neuropathologica Communications. 8: 221 |
| Bommareddy PK, Lowe DB, Kaufman HL, et al. (2019) Multi-parametric flow cytometry staining procedure for analyzing tumor-infiltrating immune cells following oncolytic herpes simplex virus immunotherapy in intracranial glioblastoma. Journal of Biological Methods. 6 |
| Wang L, Ning J, Wakimoto H, et al. (2019) Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells. Molecular Therapy Oncolytics. 13: 58-66 |